About Facio Therapies
Facio Therapies, founded in 2014, is a Netherlands-based company focused on curing FSHD by developing a causal therapy that suppresses the toxic protein DUX4. Facio is working with leaders in the field to develop a cost-effective and accessible causal therapy for as many patients with FSHD as possible in the fastest way possible. Because it is run by people for people with FSHD, the business model is focused on having a positive impact on quality of life rather than maximizing financial gain. Facio's founders, Kees van der Graaf (Netherlands), Bill Moss (Australia) and Neil Camarta (Canada) are leaders in the FSHD community.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Pharma
